Fischer, Luca http://orcid.org/0000-0003-2444-416X
Jiang, Linmiao
Bittenbring, Joerg Thomas
Huebel, Kai
Schmidt, Christian
Duell, Johannes
Metzner, Bernd
Krauter, Juergen
Glass, Bertram
Huettmann, Andreas
Schaefer-Eckart, Kerstin
Silkenstedt, Elisabeth
Klapper, Wolfram
Hiddemann, Wolfgang
Unterhalt, Michael
Dreyling, Martin
Hoster, Eva
,
Funding for this research was provided by:
Universitätsklinik München
Article History
Received: 8 March 2023
Accepted: 24 July 2023
First Online: 8 August 2023
Declarations
:
: All patients provided written informed consent. All procedures were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). Both trials were performed in accordance with local regulations and approved by the responsible ethics committees (Ethikkommission der Medizinischen Fakultät Göttingen (GLSG1996); Ethikkommission der Medizinischen Fakultät der LMU (GLSG2000). The trials were started before preregistration was implemented and are therefore not registered.
: Bittenbring JT received travel support and honoraria from Gilead, Incyte and MDS.Hübel K served as an advisor and consultant for Roche, Celgene/BMS, Gilead, Incyte, EUSA, Novartis, received honoraria from Roche, Celgene/BMS, Servier, EUSA, BeiGene, Novartis and research support from Roche, Alexion, Celgene/BMS, Janssen, Incyte.Schmidt C served as a consultant for Novartis, Kite/Gilead, Takeda, BMS, received honoraria from Novartis, Kite/Gilead, travel support from Novartis, Kite/Gilead, Takeda, BMS, Janssen and research funding from Kite/Gilead.Glaß B served as a consultant for BMS, Roche, Riemser, Kite, Novartis, served in the speakers bureau of Roche and received research funding from Roche and Riemser.Hüttmann A received honoraria from Celgene, Gilead, Takeda, served as a consultant for Lead Discovery Center GmbH and is a member of a Board or Advisory Committee for Takeda.Hiddemann W received research support from Roche.Unterhalt M received research support from Roche.Dreyling M received speaker’s honoraria from Amgen, Astra Zeneca, Bayer, BMS/Celgene, Gilead/Kite, Incyte, Janssen, Novartis, Roche, served on scientific advisory bords for Astra Zeneca, Bayer, Beigene, BMS/Celgene, Genmab, Gilead/Kite, Incyte, Janssen, Lilly/Loxo, Morphosys, Novartis, Roche and received research support from Abbvie, Bayer, BMS/Celgene, Gilead/Kite, Janssen, Roche.All remaining authors have declared no conflicts of interest.